Foto 1 di 1
The Business of Healthcare Innovation, Burns 9780521547680 Spedizione gratuita veloce^;-
Condizione:
Prezzo:
US $47,89
CircaEUR 44,48
- Compralo SubitoThe Business of Healthcare Innovation, Burns 9780521547680 Spedizione gratuita veloce^;
Spedizione:
Oggetto che si trova a: NY, Stati Uniti
Consegna:
Consegna prevista tra il gio 9 mag e il mar 14 mag a 43230
Restituzioni:
Restituzioni entro 30 giorni. L'acquirente paga le spese di spedizione per la restituzione dell'oggetto. Vedi i dettagli- per maggiori informazioni sulle restituzioni
Pagamenti:
Fai shopping in tutta sicurezza
Informazioni sul venditore
- 97,9% di Feedback positivi
Registrato come venditore professionale
Il venditore si assume la piena responsabilità della messa in vendita dell'oggetto.
Numero oggetto eBay:313567711781
Specifiche dell'oggetto
- Condizione
- ISBN
- 9780521547680
- EAN
- 9780521547680
- Publication Year
- 2005
- Type
- Textbook
- Format
- Perfect
- Language
- English
- Publication Name
- Business of Healthcare Innovation
- Item Height
- 1.3in
- Item Length
- 9.8in
- Publisher
- Cambridge University Press
- Item Width
- 6.9in
- Item Weight
- 27.7 Oz
- Number of Pages
- 398 Pages
Informazioni su questo prodotto
Product Information
Robert Lawton Burns focuses on the key role of the 'producers' as the main source of innovation in this wide-ranging analysis of business trends in the manufacturing branch of the health care industry. Written by industry academics and executives, the book provides a detailed overview of the pharmaceutical, biotechnology, genomics/proteomics, medical device and information technology sectors. Most importantly, it describes the growing convergence between these sectors and the need for executives in one sector to increasingly draw upon trends in the others.
Product Identifiers
Publisher
Cambridge University Press
ISBN-10
0521547687
ISBN-13
9780521547680
eBay Product ID (ePID)
44582001
Product Key Features
Publication Name
Business of Healthcare Innovation
Format
Perfect
Language
English
Publication Year
2005
Type
Textbook
Number of Pages
398 Pages
Dimensions
Item Length
9.8in
Item Height
1.3in
Item Width
6.9in
Item Weight
27.7 Oz
Additional Product Features
Lc Classification Number
R855.3.B87 2005
Reviews
This book is an up-to-date and authoritative description of innovation in the healthcare industry. While there is substantial change in how healthcare services are delivered and reimbursed, the focus here is on innovaiton in products. This is appropriate as new pharmaceuticals and devices generate the greatest new benefit to patients and value to our economy. In addition to related subject matter, the book provides a comprehensive discussion about the biotechnology industry, in particular those companies devoted to the healthcare sector: their innovations, financing, development, evolution, and how they are regulated on a global basis....|9780521547680|, 'This book is an up-to-date and authoritative description of innovation in the healthcare industry. While there is substantial change in how healthcare services are delivered and reimbursed, the focus here is on innovation in products. This is appropriate as new pharmaceuticals and devices generate the greatest new benefit to patients and value to our economy. In addition to related subject matter, the book provides a comprehensive discussion about the biotechnology industry, in particular those companies devoted to the healthcare sector: their innovations, financing, development, evolution, and how they are regulated on a global basis. The profound impact biopharmaceuticals are having on serious diseases is effectively illustrated by cogent examples of breakthrough medicines and the companies that developed them. This book presents compelling evidence that the pharmaceutical industry, with its productivity gap, has become evermore dependent on the biotechnology industry as its engine of innovation for new products.' L Patrick Gage, Ph.D., Venture Partner, Flagship Ventures, 'Never has the need for a reasoned analysis of the business of healthcare innovation been greater. The costs of innovation have been escalating steadily for decades and the willingness and ability of society to fund ongoing innovation is under strain. At the same time, as healthcare becomes increasingly complex those participating - basic and discovery scientists, product developers, providers, and those involved in regulating, managing and funding the system - become more specialized and find it harder to understand the industry as a whole. Yet the components of the system are not independent of one another and we ignore the inter-relationships at our peril. This badly needed volume will be a compelling read for those directly involved in healthcare, for students aspiring to enter the system, and for the rest of us who one way or another collide with the system more often than we might like.' Dr Peter A. Tollman, Vice President and Director, The Boston Consulting Group, "Never has the need for a reasoned analysis of the business of healthcare innovation been greater. The costs of innovation have been escalating steadily for decades and the willingness and ability of society to fund ongoing innovation is under strain. At the same time, as heathcare becomes increasingly complex those participating -- basic and discovery scientists, product developers, providers, and those involved in regulating, managing and funding the system -- become more specialized and find it harder to understand the industry as a whole. Yet the components of the system are not independent of one another and we ignore the inter-relationships at our peril. This badly needed volume will be a compelling read for those directly involved in healthcare, for students aspiring to enter the system, and for the rest of us who one way or another collde with the system more often than we might like." Dr. Peter A. Tollman, Vice President and Director of The Boston Consulting Group, 'This book presents a concise analysis of the factors influencing innovation in the health supplier sector. It is highly recommended for programs in health services management and will also be of interest to health care executives seeking to obtain a deeper understanding of the supplier side of the industry.' Stephen M. Shortell, Ph.D., Dean, School of Public Health, UC - Berkeley, 'The business of medical technology is virtually ignored in most academic books, despite the sector's substantial size, growth rate, complexity, and promise. The Business of Healthcare Innovation ably fills this gap. It couples authoritative, complete descriptions of each of the major components within medical technology - pharmaceuticals, biotechnology, medical devices, and information - with cogent analyses of how adept managers gain and sustain competitive advantage.' Regina Herzlinger, Harvard Business School, 'The business of medical technology is virtually ignored in most academic books, despite the sector's substantial size, growth rate, complexity, and promise. The Business of Healthcare Innovation ably fills this gap. It couples authoritative, complete descriptions of each of the major components within medical technology - pharmaceuticals, biotechnology, medical devices, and information - with cogent analyses of how adept managers gain and sustain competitive advantage.' Professor Regina Herzlinger, Harvard Business School, 'The health care sector of the developed world's economies has become one of the most significant in terms of both cost and human benefits created. The authors have done an excellent job of providing a clear understanding of the basic industry platforms that create both the product innovation and their associated benefits and costs. The book also provides valuable insights as to how the diverse segments converge to create the rapidly changing health care experience impacting both patients and payors.' James Vincent, Chairman and CEO (ret.), Biogen, 'This timely and well-written volume provides a needed analysis of the health care sector that delivers technological innovation. I am particularly impressed with both the breadth and depth of coverage that Lawton Burns and colleagues achieve here, given the expansive topic.' Edward J. Zajac, James F. Berè Distinguished Professor of Management and Organizations, Kellogg School of Management, ‘Never has the need for a reasoned analysis of the business of healthcare innovation been greater. The costs of innovation have been escalating steadily for decades and the willingness and ability of society to fund ongoing innovation is under strain. At the same time, as healthcare becomes increasingly complex those participating - basic and discovery scientists, product developers, providers, and those involved in regulating, managing and funding the system - become more specialized and find it harder to understand the industry as a whole. Yet the components of the system are not independent of one another and we ignore the inter-relationships at our peril. This badly needed volume will be a compelling read for those directly involved in healthcare, for students aspiring to enter the system, and for the rest of us who one way or another collide with the system more often than we might like.’Dr Peter A. Tollman, Vice President and Director, The Boston Consulting Group, 'All sectors of the healthcare products industry are not the same. The Business of Healthcare Innovation provides an interesting primer on the various product categories while framing key questions regarding the future evolution of this fascinating industry.' Arthur D. Collins, Jr, Chairman and Chief Executive Officer, Medtronic, Inc., 'This book presents a concise analysis of the factors influencing innovation in the health supplier sector. It is highly recommended for programs in health services management and will also be of interest to health care executives seeking to obtain a deeper understanding of the supplier side of the industry.' Stephen M. Shortell, Dean, School of Public Health, University of California, Berkeley, 'This timely and well-written volume provides a needed analysis of the health care sector that delivers technological innovation. I am particularly impressed with both the breadth and depth of coverage that Lawton Burns and colleagues achieve here, given the expansive topic.' Edward J. Zajac, James F. Ber Distinguished Professor of Management and Organizations , Kellogg School of Management, ‘This timely and well-written volume provides a needed analysis of the health care sector that delivers technological innovation. I am particularly impressed with both the breadth and depth of coverage that Lawton Burns and colleagues achieve here, given the expansive topic.’Edward J. Zajac , James F. Beré Distinguished Professor of Management and Organizations , Kellogg School of Management, ‘All sectors of the healthcare products industry are not the same. The Business of Healthcare Innovation provides an interesting primer on the various product categories while framing key questions regarding the future evolution of this fascinating industry.’Arthur D. Collins, Jr., Chairman & Chief Executive Officer, Medtronic, Inc., ‘The business of medical technology is virtually ignored in most academic books, despite the sector's substantial size, growth rate, complexity, and promise. The Business of Healthcare Innovation ably fills this gap. It couples authoritative, complete descriptions of each of the major components within medical technology - pharmaceuticals, biotechnology, medical devices, and information - with cogent analyses of how adept managers gain and sustain competitive advantage.’Professor Regina Herzlinger, Harvard Business School, ‘This book presents a concise analysis of the factors influencing innovation in the health supplier sector. It is highly recommended for programs in health services management and will also be of interest to health care executives seeking to obtain a deeper understanding of the supplier side of the industry.’Stephen M. Shortell, Ph.D., Dean, School of Public Health, UC - Berkeley, 'All sectors of the healthcare products industry are not the same. The Business of Healthcare Innovation provides an interesting primer on the various product categories while framing key questions regarding the future evolution of this fascinating industry.' Arthur D. Collins, Jr., Chairman & Chief Executive Officer, Medtronic, Inc., The profound impact biopharmaceuticals are having on serious diseases is effectively illustrated by cogent examples of breakthrough medicines and the companies that developed them. This book presents compelling evidence that the pharmaceutical industry, with its productivity gap, has become evermore dependent on the biotechnology industry as its engine of innovation for new products." L Patrick Gage, Ph.D., Venture Partner, Flagship Ventures, ‘This book is an up-to-date and authoritative description of innovation in the healthcare industry. While there is substantial change in how healthcare services are delivered and reimbursed, the focus here is on innovation in products. This is appropriate as new pharmaceuticals and devices generate the greatest new benefit to patients and value to our economy. In addition to related subject matter, the book provides a comprehensive discussion about the biotechnology industry, in particular those companies devoted to the healthcare sector: their innovations, financing, development, evolution, and how they are regulated on a global basis. The profound impact biopharmaceuticals are having on serious diseases is effectively illustrated by cogent examples of breakthrough medicines and the companies that developed them. This book presents compelling evidence that the pharmaceutical industry, with its productivity gap, has become evermore dependent on the biotechnology industry as its engine of innovation for new products.’L Patrick Gage, Ph.D., Venture Partner, Flagship Ventures, "This book presents a concise analysis of the factors influencing innovation in the heath supplier sector. It is highly recommended for programs in health services management and will also be of interest to health care executives seeking to obtain a deeper understanding of the supplier side of the industry." Stephen M. Shortell, Ph.D, Dean, School of Public Health, UC Berkely, 'This book is an up-to-date and authoritative description of innovation in the healthcare industry. While there is substantial change in how healthcare services are delivered and reimbursed, the focus here is on innovation in products. This is appropriate as new pharmaceuticals and devices generate the greatest new benefit to patients and value to our economy. In addition to related subject matter, the book provides a comprehensive discussion about the biotechnology industry, in particular those companies devoted to the healthcare sector: their innovations, financing, development, evolution, and how they are regulated on a global basis. The profound impact biopharmaceuticals are having on serious diseases is effectively illustrated by cogent examples of breakthrough medicines and the companies that developed them. This book presents compelling evidence that the pharmaceutical industry, with its productivity gap, has become evermore dependent on the biotechnology industry as its engine of innovation for new products.' L Patrick Gage, Venture Partner, Flagship Ventures, "This timely and well-written volume provides a needed analysis of the health care sector that delivers technological innovation. I am particularly impressed with both the breadth and depth of coverage that Lawton Burns and colleagues achieve here, given the expansive topic." Edward J. Zajac, Kellogg School of Management, 'This timely and well-written volume provides a needed analysis of the health care sector that delivers technological innovation. I am particularly impressed with both the breadth and depth of coverage that Lawton Burns and colleagues achieve here, given the expansive topic.' Edward J. Zajac , James F. Beré Distinguished Professor of Management and Organizations , Kellogg School of Management, ‘The health care sector of the developed world's economies has become one of the most significant in terms of both cost and human benefits created. The authors have done an excellent job of providing a clear understanding of the basic industry platforms that create both the product innovation and their associated benefits and costs. The book also provides valuable insights as to how the diverse segments converge to create the rapidly changing health care experience impacting both patients and payors.’James Vincent, Chairman and CEO (ret.), Biogen, 'Never has the need for a reasoned analysis of the business of healthcare innovation been greater. The costs of innovation have been escalating steadily for decades and the willingness and ability of society to fund ongoing innovation is under strain. At the same time, as healthcare becomes increasingly complex those participating - basic and discovery scientists, product developers, providers, and those involved in regulating, managing and funding the system - become more specialized and find it harder to understand the industry as a whole. Yet the components of the system are not independent of one another and we ignore the inter-relationships at our peril. This badly needed volume will be a compelling read for those directly involved in healthcare, for students aspiring to enter the system, and for the rest of us who one way or another collide with the system more often than we might like.' Peter A. Tollman, Vice President and Director, The Boston Consulting Group
Table of Content
Acknowledgements; Preface; 1. The business of healthcare innovation in the Wharton School curriculum Lawton R. Burns; Part I. The Life Sciences: 2. The pharmaceutical sector John Northrup; 3. The biotechnology sector Cary G. Pfeffer; 4. Biotechnology business and revenue models: the dynamic of technological evolution and capital market ingenuity Stephen M. Sammut; 5. Mergers, acquisitions, and the advantages of scale in the pharmaceutical sector Lawton R. Burns, Sean Nicholson and John Evans; Part II. Devices and Information Technologies: 6. The medical device sector Kurt Kruger; 7. Healthcare information technology sector Jeff C. Goldsmith; 8. Healthcare innovation across sectors: convergences and divergences Lawton R. Burns and Stephen M. Sammut.
Copyright Date
2005
Target Audience
Scholarly & Professional
Topic
Health Care Delivery, Entrepreneurship, Allied Health Services / Medical Technology, Forecasting
Lccn
2005-046981
Dewey Decimal
610/.28
Dewey Edition
22
Illustrated
Yes
Genre
Business & Economics, Medical
Descrizione dell'oggetto fatta dal venditore
Informazioni sul venditore professionale
WRAP Ltd
Mubin Ahmed
2 Lester Way
Wallingford
OX10 9TA
United Kingdom
Numero Partita IVA:
- GB 724498118
Numero registro delle imprese:
- 03800600
Certifico che tutte le mie attività di vendita saranno conformi alle leggi e ai regolamenti dell'Unione Europea.
Il venditore si assume la piena responsabilità della messa in vendita dell'oggetto.
Numero oggetto eBay:313567711781
Spedizione e imballaggio
Luogo in cui si trova l'oggetto:
NY, Stati Uniti
Destinazione:
Tutto il mondo
Paesi in cui non si effettua la spedizione:
Arabia Saudita, Bahrain, Barbados, Brasile, Bulgaria, Cipro, Emirati Arabi Uniti, Federazione Russa, Giordania, Guadalupa, Guyana francese, Indonesia, Iraq, Irlanda, Israele, Kuwait, Libano, Libia, Martinica, Mauritius, Nuova Caledonia, Oman, Polinesia francese, Porto Rico, Qatar, Regno Unito, Riunione, Slovenia, Sud Africa, Turchia, Ucraina, Venezuela
| Spedizione e imballaggio | A | Servizio | Consegna*Vedi le note di consegna |
|---|---|---|---|
| Spedizione gratuita | Stati Uniti | Economica (USPS Media MailTM) | Consegna prevista tra il gio 9 mag e il mar 14 mag a 43230 |
| Tempi di imballaggio |
|---|
| La spedizione di solito viene effettuata entro 2 giorni lavorativi dalla ricezione del pagamento. |
| Imposte |
|---|
| Potrebbero essere applicate tasse al momento del pagamento. Ulteriori informazioniUlteriori informazioni sul pagamento delle imposte sugli acquisti eBay. |
Imposte sulle vendite per oggetto num. 313567711781
Imposte sulle vendite per oggetto num. 313567711781
Il venditore riscuote l'imposta sulle vendite per gli oggetti spediti ai seguenti Stati:
| Stato | Aliquota dell'imposta sulla vendita |
|---|
Regole sulle restituzioni
| Dopo aver ricevuto l'oggetto, contatta il venditore entro | Modalità di rimborso | Spese di restituzione |
|---|---|---|
| 30 giorni | Rimborso in contanti | L'acquirente paga le spese di spedizione per la restituzione dell'oggetto |
Clicca quiqui per ulteriori dettagli sulle Restituzioni. Per le transazioni idonee, sei coperto dal programma Garanzia cliente eBay se ricevi un oggetto non conforme alla descrizione.
Le spese di spedizione per la restituzione sono a carico dell'acquirente.
| Informazioni sulla restituzione |
|---|
| Restituzioni accettate |
Dettagli di pagamento
Metodi di pagamento
Nota: nella procedura di pagamento potrebbero non essere disponibili alcuni metodi di pagamento a causa della valutazione del rischio dell'acquirente.
Categorie più popolari di questo Negozio
Registrato come venditore professionale
Feedback del venditore (511.655)
s***c (961)- Feedback lasciato dall'acquirente.
Mese scorso
Acquisto verificato
Excellent seller! Item as described and shipped quickly. Highly recommended!! Thank you!!
e***e (4971)- Feedback lasciato dall'acquirente.
Mese scorso
Acquisto verificato
GREAT SERVICE! PROMPT DELIVERY!
b***b (1536)- Feedback lasciato dall'acquirente.
Mese scorso
Acquisto verificato
A++++++++++
Valutazioni e recensioni del prodotto
Vedi altro:
- Narrativa per bambini e ragazzi, di business,
- Libri e riviste per bambini e ragazzi, di business,
- Libri e riviste di narrativa The Walking Dead,
- Libri e riviste di narrativa The Walking Dead in italiano,
- Libri e riviste di narrativa The Walking Dead in inglese,
- Libri e riviste di narrativa copertine rigide The Walking Dead